| Literature DB >> 15163825 |
Andrew J Wheaton1, Arijitt Borthakur, Erik M Shapiro, Ravinder R Regatte, Sarma V S Akella, J Bruce Kneeland, Ravinder Reddy.
Abstract
The feasibility of using sodium magnetic resonance (MR) imaging to detect proteoglycan loss in early-stage osteoarthritis is evaluated. Fixed charge density (FCD) maps were calculated from sodium MR imaging data collected in nine healthy volunteers and three individuals with symptoms of early-stage osteoarthritis by using a 4.0-T clinical MR imaging unit. Data from the healthy individuals revealed a mean FCD of -182 mmol/L +/- 9. Data from the symptomatic subjects revealed focal regions of decreased FCD, with mean values ranging from -108 to -144 mmol/L, indicating proteoglycan loss from the cartilage matrix. The data suggest that sodium MR imaging has potential for use as a quantitative diagnostic tool to measure changes in proteoglycan content in early-stage osteoarthritis. Copyright RSNA, 2004Entities:
Mesh:
Substances:
Year: 2004 PMID: 15163825 DOI: 10.1148/radiol.2313030521
Source DB: PubMed Journal: Radiology ISSN: 0033-8419 Impact factor: 11.105